Advancing a Promising Anti-cancer Agent

Total synthesis of halichondrin enables Phase I clinical trial

Collaboration with Eisai

Harvard chemists have achieved what a new paper calls a “landmark in drug discovery” X

New License in CRISPR Human Therapeutics

Verve Therapeutics aims to develop therapies to protect against heart disease in adults

Toward Novel Cell Therapies

Immune-silent stem cell technology licensed to Sana Biotechnology

Stem-cell Advances

Innovations may lead to cell therapies for any patient with any disease. X